Troubled United Arab Emirates drugmaker Julphar says it is focusing on “improving quality procedures” to overcome bans on exports to countries including Saudi Arabia, Bahrain, Kuwait and Oman. A new management team is trying to revive the flagging firm’s fortunes after CEO Jerome Carle departed on 8 December.
Julphar’s dramatic downturn in fortunes over the past year has stemmed from export bans following inspections of its key facility...





